NPR on Instagram: "Federal regulators have approved a pill version of the popular weight loss drug Wegovy, which is currently only available as an injection. The pills could hit the market by early next year.⁠ ⁠ Meanwhile, injectable GLP-1 weight loss drugs have transformed obesity care, but they don’t work for everyone.⁠ ⁠ Roughly half of those who take GLP1s lose 15% or more of their bodyweight, but a minority — about one in six — lose very little. Doctors specializing in obesity care say this

CNN on Instagram: "The FDA has approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, which retains the same active ingredient as the original, allowing for an alternative to the weekly injections currently offered. CNN's Meg Tirrell reports. Read more at the link in our bio."